The US Food and Drug Administration (FDA) has approved cenobamate (Xcopri, SK Life Science) for the treatment of partial-onset seizures in adult patients with epilepsy. Today's approval was based on results from two randomized controlled trials that ...
from Google Alert - health https://ift.tt/37ssAlx
via IFTTT
0 comments:
Post a Comment